3 Enzyme Maker, Diversified Chemical Group and Helmet Stocks With a Strong Future Roadmap: Advanced Enzyme Technologies, Godrej Industries and Studds Accessories

Enzyme maker, diversified chemical group and helmet stocks give investors exposure to enzymes, chemicals and safety gear used in food, industry and on the road. Volumes, pricing and margins decide how much of that demand turns into profit.

This list covers three enzyme maker, diversified chemical group and helmet stocks: Advanced Enzyme Technologies for enzymes and probiotics for food, nutrition, pharma and animal feed, Godrej Industries for chemicals, along with stakes in listed group companies in real estate, consumer products and agri-business, and a finance arm and Studds Accessories for motorcycle helmets and riding accessories sold in India and overseas. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Enzyme Maker, Diversified Chemical Group and Helmet Stocks?

Enzyme maker, diversified chemical group and helmet stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.

Enzyme Maker, Diversified Chemical Group and Helmet Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three enzyme maker, diversified chemical group and helmet stocks as of the 14 Oct 2026 close.

Among healthcare, chemicals and consumer stocks, all three trade at a discount to their industry P/E multiples.

Why Do Enzyme Maker, Diversified Chemical Group and Helmet Stocks Have a Strong Roadmap in India?

Enzyme maker, diversified chemical group and helmet stocks have a strong roadmap in India because enzyme demand from food and pharma, group company value and two-wheeler ownership keep adding volumes for these firms. Three drivers stand out.

• Enzyme demand: Food, nutrition and pharma makers use enzymes and probiotics.
• Group stakes: Listed group companies add value to the parent.
• Two-wheeler riders: Safety rules and rising incomes lift helmet demand.

Advanced Enzyme Technologies: Enzymes and Probiotics Build the Next Leg

Advanced Enzyme's roadmap rests on enzymes and probiotics for food, nutrition, pharma and animal feed, with a wide industrial customer base supporting revenue.

Revenue grew from Rs 535.80 crore in FY22 to Rs 780.59 crore in FY26, a 45.7% rise, and FY26 revenue was 16.5% higher than FY25. FY26 net profit rose 29.6% to Rs 173.61 crore. Over four years, net profit rose from Rs 123.80 crore in FY22 to Rs 173.61 crore. In Q1 FY27, revenue grew 4.1% to Rs 202.81 crore. Operating margin was 37.06% in FY26.

Debt to equity is 0.02 and return on equity is 10.34%. FY26 operating cash flow was Rs 156.78 crore against capital expenditure of Rs 52.38 crore. Advanced Enzyme paid a dividend of Rs 5.35 per share for FY26, a yield of 2.02%. At a P/E of 17.28 against an industry P/E of 37.59, the stock trades below its industry multiple.

What to watch: The P/E of 17.28 against an industry P/E of 37.59 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

Godrej Industries: Chemicals and Group Holdings Build the Next Leg

Godrej Industries' roadmap rests on chemicals, along with stakes in listed group companies in real estate, consumer products and agri-business, and a finance arm, with its chemical business and holdings in other group companies widening the earnings base.

Revenue grew from Rs 15,064.67 crore in FY22 to Rs 25,980.60 crore in FY26, a 72.5% rise, and FY26 revenue was 18.5% higher than FY25. FY26 net profit rose 29.8% to Rs 2,411.91 crore. Over four years, net profit rose from Rs 992.43 crore in FY22 to Rs 2,411.91 crore. In Q1 FY27, revenue grew 11.2% to Rs 6,360.30 crore. Operating margin was 26.91% in FY26.

Return on equity is 11.10%. At a P/E of 15.29 against an industry P/E of 36.60, the stock trades below its industry multiple.

What to watch: The P/E of 15.29 against an industry P/E of 36.60 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

Studds Accessories: Helmets and Riding Gear Build the Next Leg

Studds' roadmap rests on motorcycle helmets and riding accessories sold in India and overseas, with rising two-wheeler use and safety awareness supporting volumes.

Revenue grew from Rs 467.98 crore in FY22 to Rs 645.75 crore in FY26, a 38.0% rise, and FY26 revenue was 8.4% higher than FY25. FY26 net profit rose 18.7% to Rs 82.65 crore. Over four years, net profit rose from Rs 28.64 crore in FY22 to Rs 82.65 crore. In Q1 FY27, revenue grew 13.8% to Rs 172.92 crore. Operating margin was 21.25% in FY26.

Debt to equity is 0.02 and return on equity is 15.80%. FY26 operating cash flow was Rs 86.42 crore against capital expenditure of Rs 47.04 crore. Studds paid a dividend of Rs 3 per share for FY26, a yield of 0.72%. At a P/E of 21.92 against an industry P/E of 36.50, the stock trades below its industry multiple.

What to watch: The P/E of 21.92 against an industry P/E of 36.50 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

Best Enzyme Maker, Diversified Chemical Group and Helmet Stocks in India: Advanced Enzyme vs Godrej Industries vs Studds on Key Financials

Among the best enzyme maker, diversified chemical group and helmet stocks in India, Advanced Enzyme leads on FY26 operating margin and dividend yield; Godrej Industries leads on FY26 revenue growth and FY26 net profit growth; Studds leads on Q1 FY27 revenue growth and return on equity. The table puts the numbers side by side.

Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Enzyme Maker, Diversified Chemical Group and Helmet Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen enzyme maker, diversified chemical group and helmet stocks and shortlist enzyme maker, diversified chemical group and helmet stocks to buy.

1. Compare each stock's P/E with its industry P/E, which differs by company here.
2. Check revenue growth, operating margin and cash flow together.
3. Check whether revenue growth is turning into profit growth, not only sales.
4. Read operating cash flow against capital expenditure to see how growth is funded.
5. Watch debt to equity and interest cover before sizing a position.
6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these enzyme maker, diversified chemical group and helmet stocks

Risks to Consider Before Investing in Enzyme Maker, Diversified Chemical Group and Helmet Stocks

• Consumer demand: Spending patterns can shift sales between quarters.
• Input costs: Changes in raw material prices can affect margins.
• Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track Advanced Enzyme, Godrej Industries and Studds live.

Final Take: Which Stock Has the Strongest Roadmap?

These three healthcare, chemicals and consumer stocks cover enzymes, chemicals and helmets. Advanced Enzyme leads on FY26 operating margin and dividend yield; Godrej Industries leads on FY26 revenue growth and FY26 net profit growth; Studds leads on Q1 FY27 revenue growth and return on equity.

Across enzyme maker, diversified chemical group and helmet stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the enzyme maker, diversified chemical group and helmet stocks to buy discussed here.

FAQs on Enzyme Maker, Diversified Chemical Group and Helmet Stocks

Which are the best enzyme maker, diversified chemical group and helmet stocks in India with a strong roadmap?

Ans. Advanced Enzyme Technologies, Godrej Industries and Studds Accessories stand out for their roadmaps in enzymes, chemicals and helmets. FY26 revenue growth was 16.5% at Advanced Enzyme, 18.5% at Godrej Industries and 8.4% at Studds, and return on equity ranges from 10.34% to 15.80%.

Is Advanced Enzyme Technologies a good stock to buy now?

Ans. Advanced Enzyme Technologies has a debt to equity ratio of 0.02, a return on equity of 10.34% and a P/E of 17.28 against an industry P/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Advanced Enzyme, Godrej Industries and Studds?

Ans. The P/E ratio is 17.28 for Advanced Enzyme (industry 37.59), 15.29 for Godrej Industries (industry 36.60) and 21.92 for Studds (industry 36.50). All of them trade below the industry multiple.

Which of these enzyme maker, diversified chemical group and helmet stocks has the highest return on equity?

Ans. Studds Accessories has the highest return on equity at 15.80%, followed by Godrej Industries at 11.10% and Advanced Enzyme Technologies at 10.34%.

What are the risks of investing in enzyme maker, diversified chemical group and helmet stocks?

Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.

How did Advanced Enzyme, Godrej Industries and Studds perform in Q1 FY27?

Ans. Advanced Enzyme Technologies reported revenue of Rs 202.81 crore, up 4.1% year on year. Godrej Industries reported revenue of Rs 6,360.30 crore, up 11.2% year on year. Studds Accessories reported revenue of Rs 172.92 crore, up 13.8% year on year.

Do enzyme maker, diversified chemical group and helmet stocks pay dividends?

Ans. Advanced Enzyme and Studds pay dividends. The dividend yield is 2.02% for Advanced Enzyme and 0.72% for Studds, based on dividends declared for FY26.

How can I invest in enzyme maker, diversified chemical group and helmet stocks in India?

Ans. You can buy enzyme maker, diversified chemical group and helmet stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.